那法瑞林治疗子宫内膜异位症所致不孕症

Nafarelin in the treatment of infertility caused by endometriosis.

作者信息

Barlow D H

机构信息

Nuffield Department of Obstetrics and Gynecology, University of Oxford, United Kingdom.

出版信息

Am J Obstet Gynecol. 1990 Feb;162(2):576-9. doi: 10.1016/0002-9378(90)90434-9.

DOI:10.1016/0002-9378(90)90434-9

PMID:2137973

Abstract

Patients with infertility caused by endometriosis may be managed by expectant strategies, surgery, or pharmacologic intervention. The relative benefits conferred by each of these approaches remain to be confirmed. Data gathered thus far suggest, however, that nafarelin, a gonadotropin-releasing hormone agonist, may be associated with fecundity rates as low as those seen after surgical intervention.

摘要

子宫内膜异位症所致不孕症患者可采用期待疗法、手术或药物干预进行治疗。这些治疗方法各自的相对益处仍有待证实。然而，迄今为止收集的数据表明，促性腺激素释放激素激动剂那法瑞林的妊娠率可能与手术干预后的妊娠率一样低。